Singapore clarifies position on pharmaceutical cannabinoid product use, anti-drug stand not weakened: MHA, MOH

133

SINGAPORE – The authorities have clarified Singapore’s position on the use of pharmaceutical cannabinoid products here, saying that their presence is under strict frameworks and regulations and does not diminish the Republic’s zero-tolerance position on drugs.

Ga naar Bron